Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. The Company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Its product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Código de la empresaTEM
Nombre de la empresaTempus AI Inc
Fecha de salida a bolsaJun 14, 2024
Fundada en2015
Director ejecutivoMr. Eric P. Lefkofsky
Número de empleados2400
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 14
Dirección600 West Chicago Avenue
CiudadCHICAGO
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal60654
Teléfono18009765448
Sitio Webhttps://www.tempus.com/
Código de la empresaTEM
Fecha de salida a bolsaJun 14, 2024
Fundada en2015
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos